Last, we detected SARS-CoV-2–specific CD4+ and CD8+ T cells after infection and vaccination, and CD4+ T cell activation was robust and appeared indifferent to the S mutations of the B.1.1.7 and B.1.351 variants. The gene discussed is CD4; the disease is infection.